4//SEC Filing
Elliott Russell P. 4
Accession 0001178913-18-002030
CIK 0001606645other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:05 PM ET
Size
5.4 KB
Accession
0001178913-18-002030
Insider Transaction Report
Form 4
Elliott Russell P.
VP Drug Development
Transactions
- Sale
Ordinary Shares
2018-07-02$5.10/sh−142$724→ 12,584 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of re-stricted share units. This sale is mandated by the Issuer's non-discretionary policy that requires the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Documents
Issuer
Foamix Pharmaceuticals Ltd.
CIK 0001606645
Entity typeother
Related Parties
1- filerCIK 0001727807
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:05 PM ET
- Size
- 5.4 KB